| 10:00 – 10:30 | Registration and welcome coffee |
| 10:30 – 11:40 | Morning Session
Chairs: E. Lebredonchel and P. Vermeersch |
| 10:30 – 11:00 | Laboratory Medicine’s Impact on Early Detection of Metabolic Syndromes Michel Langlois – Chair EFLM Science Committee |
| 11:00 – 11:40 | The value of Laboratory tests for prevention of Neurological disorders S. Lehmann and J.L. Bayart |
| 11:40 – 12:00 | Coffee Break |
| 12:00 – 12:30 | Navigating the Future of Cardiovascular Disease Prevention A. Mebazaa |
| 12:30 – 13:00 | Kidney Health Unveiled, Predictive Biomarkers and Their Role in Early Intervention E. Cavalier – EFLM Task Group: Chronic Kidney Disease |
| 13:00 – 13:45 | Lunch Break |
| 13:45 – 15:30 | Afternoon Session
Chairs: V. Sapin and E. Cavalier |
| 13:45 – 14:10 | Preventing the side effects of N2O G. Gryzch, K. Anseeuw – EFLM TFG: Biological Markers of Diagnosis and Followup of Nitrous Oxide Abuse |
| 14:10 – 14:35 | The value of multistakeholders actions J. De Maeseneer |
| 14:35 – 15:00 | Prevention First: How Cutting-Edge Lab Tests Shape the Future of Oncology R. Van Schaik |
| 15:00 – 15:30 | Developing cost-effective strategy for prevention M. Plebani, EFLM President |
| 15:30 – 15:45 | Wrap up and Concluding Remarks – M. Oyaert and K. Peoch |
EuroMedLab Brussels 2025 Satellite Meeting
Joint Symposium between the RBLSM (Royal Belgian Society of Laboratory Medicine) and the SFBC (French Society of Clinical Chemistry)
Preventive Diagnostics: the Power of Laboratory Medicine



